Home
→
Browsing by Author

Browsing by Author "De Castro, Javier"

Now showing items 1-4 of 4

Addition of immune checkpoint inhibitors to chemotherapy vs chemotherapy alone as first-line treatment in extensive-stage small-cell lung carcinoma: a systematic review and meta-analysis

Arriola Aperribay, Edurne; González Cao, María; Domine, Manuel; De Castro, Javier; Cobo, Manuel; Bernabé, Reyes; Navarro, Alejandro; Sullivan, Ivana; Trigo, José Manuel; Mosquera, Joaquín; Crama, Leonardo; Isla, Dolores (Springer, 2022)

Introduction: The addition of immune checkpoint inhibitors (ICIs) to conventional chemotherapy (CT) as first-line treatment improves survival in extensive-stage small-cell lung cancer (ES-SCLC). The aim of this meta-analysis ...
Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

Isla, Dolores; De Castro, Javier; Juan, Oscar; Grau Cerrato, Santiago; Orofino, Javier; Gordo, Rocío; Rubio-Terrés, Carlos; Rubio-Rodríguez, Darío (Dove Medical Press, 2016)

OBJECTIVES: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are an established treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutation. According to published meta-analyses, no ...
PD-L1 Inhibitors as monotherapy for the first-line treatment of non-small-cell lung cancer in PD-L1 positive patients: a safety data network meta-analysis

García-Campelo, Rosario; Arriola Aperribay, Edurne; Campos Balea, Begoña; López-Brea, Marta; Fuentes-Pradera, José; De Castro, Javier; Aguado, Carlos; Pérez Parente, Diego; de Oro Pulido, Fidel; Ruiz-Gracia, Pedro; Rodríguez-Abreu, Delvys (MDPI, 2021)

This network meta-analysis (NMA) evaluates the safety of first-line programmed death-ligand 1 (PD-L1) inhibitor monotherapy in advanced NSCLC patients compared to platinum-based chemotherapy. We also compared the risk of ...
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Garrido, P.; Conde, Esther; De Castro, Javier; Gómez-Román, J. J.; Felip, Enriqueta; Pijuan Andujar, Lara; Isla, Dolores; Sanz, J.; Paz-Ares, L.; López-Ríos, F. (Springer, 2020)

In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) started a joint project to establish guidelines on biomarker testing in patients with advanced non-small-cell lung cancer ...

Now showing items 1-4 of 4

Search DSpace

Advanced Search

Browse

All of DSpace

My Account

In collaboration with Compliant to Partaking

Browsing by Author "De Castro, Javier"

Browsing by Author "De Castro, Javier"

Search DSpace

Browse

All of DSpace

My Account